486
Participants
Start Date
July 31, 2012
Primary Completion Date
April 30, 2014
Study Completion Date
December 31, 2014
Alirocumab
Solution for subcutaneous injection in the abdomen, thigh, or outer area of the upper arm by self-injection or by another designated person using auto-injector (also known as pre filled pen).
Placebo (for alirocumab)
Solution for subcutaneous injection in the abdomen, thigh, or outer area of the upper arm by self-injection or by another designated person using auto-injector (also known as pre filled pen).
Lipid Modifying Therapy (LMT)
Statin (rosuvastatin, simvastatin or atorvastatin) at stable dose with or without other LMT as clinically indicated.
Investigational Site Number 040402, Vienna
Investigational Site Number 710407, Parktown
Investigational Site Number 208403, Esbjerg
Investigational Site Number 710409, Somerset West
Investigational Site Number 710403, Parow
Investigational Site Number 710406, Cap Town
Investigational Site Number 710402, Cape Town
Investigational Site Number 040403, Graz
Investigational Site Number 578401, Bodø
Investigational Site Number 840408, New York
Investigational Site Number 376404, Safed
Investigational Site Number 724406, Córdoba
Investigational Site Number 724403, A Coruña
Investigational Site Number 840404, Philadelphia
Investigational Site Number 840426, Philadelphia
Investigational Site Number 840452, Washington D.C.
Investigational Site Number 250403, Dijon
Investigational Site Number 840410, Durham
Investigational Site Number 724409, Madrid
Investigational Site Number 724401, Madrid
Investigational Site Number 724405, Madrid
Investigational Site Number 840401, Charlotte
Investigational Site Number 840418, Ponte Vedra
Investigational Site Number 840456, Miami
Investigational Site Number 840406, Nashville
Investigational Site Number 752404, Gothenburg
Investigational Site Number 724404, Reus
Investigational Site Number 250402, Saint-Herblain
Investigational Site Number 840430, Cincinnati
Investigational Site Number 724402, Zaragoza
Investigational Site Number 376401, Tel Litwinsky
Investigational Site Number 840455, Evanston
Investigational Site Number 840409, St Louis
Investigational Site Number 840460, Dallas
Investigational Site Number 250401, Paris
Investigational Site Number 376402, Holon
Investigational Site Number 840422, Bountiful
Investigational Site Number 840419, Los Angeles
Investigational Site Number 840417, Bell Gardens
Investigational Site Number 840429, Long Beach
Investigational Site Number 840461, Northridge
Investigational Site Number 840412, Newport Beach
Investigational Site Number 840421, Mission Viejo
Investigational Site Number 643409, Moscow
Investigational Site Number 643413, Moscow
Investigational Site Number 643401, Moscow
Investigational Site Number 643410, Yaroslavl
Investigational Site Number 643402, Arkhangelsk
Investigational Site Number 643408, Saint Petersburg
Investigational Site Number 643406, Saint Petersburg
Investigational Site Number 643404, Saint Petersburg
Investigational Site Number 643407, Kazan'
Investigational Site Number 840428, Newport Beach
Investigational Site Number 040405, Vienna
Investigational Site Number 203405, Uherské Hradiště
Investigational Site Number 208401, Copenhagen
Investigational Site Number 376405, Jerusalem
Investigational Site Number 528410, Amsterdam
Investigational Site Number 528412, Sliedrecht
Investigational Site Number 643412, Novisibirsk
Investigational Site Number 710401, Bloemfontein
Investigational Site Number 710405, Bloemfontein
Investigational Site Number 710408, Pretoria
Investigational Site Number 710404, Rondebosch
Investigational Site Number 826402, London
Investigational Site Number 826403, London
Investigational Site Number 826408, London
Investigational Site Number 826409, London
Investigational Site Number 840415, Kansas City
Investigational Site Number 840425, Auburn
Investigational Site Number 840411, Boston
Investigational Site Number 840407, Morristown
Investigational Site Number 840424, Portland
Investigational Site Number 124404, Chicoutimi
Investigational Site Number 124401, Montreal
Investigational Site Number 124403, Québec
Investigational Site Number 124406, Sherbrooke
Investigational Site Number 124407, Toronto
Investigational Site Number 203401, Prague
Investigational Site Number 203403, Prague
Investigational Site Number 203402, Zlín
Investigational Site Number 528406, Amsterdam
Investigational Site Number 528408, Den Helder
Investigational Site Number 528402, Groningen
Investigational Site Number 528411, Leiden
Investigational Site Number 528416, Maastricht
Investigational Site Number 528409, Nieuwegein
Investigational Site Number 724408, Barcelona
Investigational Site Number 724407, L'Hospitalet de Llobregat
Investigational Site Number 752401, Stockholm
Investigational Site Number 826405, Manchester
Lead Sponsor
Regeneron Pharmaceuticals
INDUSTRY
Sanofi
INDUSTRY